These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19283770)

  • 1. Synthesis and evaluation of N-nicotinoyl-2-{2-(2-methyl-5-nitroimidazol-1-yl)ethyloxy}-D,L-glycine as a colon-specific prodrug of metronidazole.
    Kim D; Hong S; Jung S; Jung Y; Kim YM
    J Pharm Sci; 2009 Nov; 98(11):4161-9. PubMed ID: 19283770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of sulfate conjugated metronidazole as a colon-specific prodrug of metronidazole.
    Kim H; Lee Y; Yoo H; Kim J; Kong H; Yoon JH; Jung Y; Kim YM
    J Drug Target; 2012 Apr; 20(3):255-63. PubMed ID: 22118327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes.
    Kim W; Yang Y; Kim D; Jeong S; Yoo JW; Yoon JH; Jung Y
    Drug Des Devel Ther; 2017; 11():419-429. PubMed ID: 28243064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro evaluation of N-nicotinoylglycyl-2-(5-fluorouracil-1-yl)-D,L-glycine as a colon-specific prodrug of 5-fluorouracil.
    Lee J; Rho J; Yang Y; Kong H; Jung Y; Kim Y
    J Drug Target; 2007 Apr; 15(3):199-205. PubMed ID: 17454357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery.
    Lee Y; Kim J; Kim W; Nam J; Jeong S; Lee S; Yoo JW; Kim MS; Jung Y
    Drug Des Devel Ther; 2015; 9():4105-13. PubMed ID: 26251576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon-specific delivery of celecoxib is a potential strategy to improve toxicological and pharmacological properties of the selective Cox-2 inhibitor: implication in treatment of familiar adenomatous polyposis.
    Lee Y; Kim H; Kim W; Yoon JH; Jeong SH; Jung Y
    J Drug Target; 2012 Jul; 20(6):524-34. PubMed ID: 22632102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of N-acyl-2-(5-fluorouracil-1-yl)-D,L-glycine as a colon-specific prodrug of 5-fluorouracil.
    Lee JS; Jung YJ; Kim YM
    J Pharm Sci; 2001 Nov; 90(11):1787-94. PubMed ID: 11745736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-succinylaspart-1-yl celecoxib is a potential colon-specific prodrug of celecoxib with improved therapeutic properties.
    Lee Y; Kim J; Kim H; Kang S; Yoon JH; Kim DD; Kim YM; Jung Y
    J Pharm Sci; 2012 May; 101(5):1831-42. PubMed ID: 22334096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration.
    Yang YW; Lee JS; Kim I; Jung YJ; Kim YM
    Eur J Pharm Biopharm; 2007 May; 66(2):260-7. PubMed ID: 17182232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednisolone 21-sulfate sodium: a colon-specific pro-drug of prednisolone.
    Jung YJ; Doh MJ; Kim IH; Kong HS; Lee JS; Kim YM
    J Pharm Pharmacol; 2003 Aug; 55(8):1075-82. PubMed ID: 12956896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Lee JS; Kim YM
    J Pharm Sci; 2000 May; 89(5):594-602. PubMed ID: 10756325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEG-metronidazole conjugates: synthesis, in vitro and in vivo properties.
    Bersani C; Berna M; Pasut G; Veronese FM
    Farmaco; 2005 Sep; 60(9):783-8. PubMed ID: 16040031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of glycine-bearing celecoxib derivatives as a colon-specific mutual prodrug acting on nuclear factor-κB, an anti-inflammatory target.
    Lee S; Lee Y; Kim W; Nam J; Jeong S; Yoo JW; Kim MS; Moon HR; Jung Y
    Drug Des Devel Ther; 2015; 9():4227-37. PubMed ID: 26300626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and properties of N,N'-bis(5-aminosalicyl)-L-cystine as a colon-specific deliverer of 5-aminosalicylic acid and cystine.
    Kim H; Kim D; Choi D; Jeon H; Han J; Jung Y; Kong H; Kim YM
    Drug Deliv; 2008 Jan; 15(1):37-42. PubMed ID: 18197522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural effects of N-aromatic acyl-amino acid conjugates on their deconjugation in the cecal contents of rats: implication in design of a colon-specific prodrug with controlled conversion rate at the target site.
    Kong H; Kim H; Do H; Lee Y; Hong S; Yoon JH; Jung Y; Kim YM
    Biopharm Drug Dispos; 2011 Sep; 32(6):343-54. PubMed ID: 21800327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dextran-flufenamic acid ester as a polymeric colon-specific prodrug of flufenamic acid, an anti-inflammatory drug, for chronotherapy.
    Lee Y; Kim IH; Kim J; Yoon JH; Shin YH; Jung Y; Kim YM
    J Drug Target; 2011 Jun; 19(5):336-43. PubMed ID: 20615092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronidazole prodrugs: synthesis, physicochemical properties, stability, and ex vivo release studies.
    Mura C; Valenti D; Floris C; Sanna R; De Luca MA; Fadda AM; Loy G
    Eur J Med Chem; 2011 Sep; 46(9):4142-50. PubMed ID: 21726922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of 5-aminosalicyl-glycine as a potential colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Lee JS; Kim HH; Kim YM; Han SK
    Arch Pharm Res; 1998 Apr; 21(2):174-8. PubMed ID: 9875427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and properties of 5-aminosalicyl-taurine as a colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Kim HH; Kong HS; Kim YM
    Arch Pharm Res; 2003 Apr; 26(4):264-9. PubMed ID: 12735682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid.
    Yamaguchi T; Sasaki K; Kurosaki Y; Nakayama T; Kimura T
    J Drug Target; 1994; 2(2):123-31. PubMed ID: 7915179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.